Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Aerie Pharmaceuticals is a drug manufacturers-specialty & generic business based in the US. Aerie Pharmaceuticals shares (AERI) are listed on the NASDAQ and all prices are listed in US Dollars. Aerie Pharmaceuticals employs 376 staff and has a trailing 12-month revenue of around $213.9 million.
How to buy Aerie Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AERI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Finder Award
Finder Award
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Aerie Pharmaceuticals stock price (NASDAQ: AERI)
Use our graph to track the performance of AERI stocks over time.Aerie Pharmaceuticals shares at a glance
Information last updated 2023-02-26.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $4.81 - $15.37 |
| 50-day moving average | $15.19 |
| 200-day moving average | $10.24 |
| Wall St. target price | $15.35 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.47 |
Buy Aerie Pharmaceuticals stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 6 of 6
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Aerie Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aerie Pharmaceuticals price performance over time
Historical closes compared with the close of $0 from 2022-12-02
| 1 week (2023-03-17) | nan% |
|---|---|
| 1 month (2023-02-24) | nan% |
| 3 months (2022-12-24) | nan% |
| 6 months (2022-09-28) | -100.00% |
| 1 year (2022-03-25) | -100.00% |
|---|---|
| 2 years (2021-03-26) | -100.00% |
| 3 years (2020-03-27) | 13.05 |
| 5 years (2018-03-28) | 53.75 |
Aerie Pharmaceuticals financials
| Revenue TTM | $213.9 million |
|---|---|
| Gross profit TTM | $167.3 million |
| Return on assets TTM | -4.59% |
| Return on equity TTM | -2255.01% |
| Profit margin | -17.09% |
| Book value | $-3.32 |
| Market capitalisation | $753.6 million |
TTM: trailing 12 months
Aerie Pharmaceuticals share dividends
We're not expecting Aerie Pharmaceuticals to pay a dividend over the next 12 months.
Aerie Pharmaceuticals share price volatility
Over the last 12 months, Aerie Pharmaceuticals's shares have ranged in value from as little as $4.81 up to $15.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aerie Pharmaceuticals's is -0.062. This would suggest that Aerie Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aerie Pharmaceuticals has bucked the trend.
Aerie Pharmaceuticals overview
Aerie Pharmaceuticals, Inc. , a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
Frequently asked questions
What percentage of Aerie Pharmaceuticals is owned by insiders or institutions?Currently 1.791% of Aerie Pharmaceuticals shares are held by insiders and 102.995% by institutions. How many people work for Aerie Pharmaceuticals?
Latest data suggests 376 work at Aerie Pharmaceuticals. When does the fiscal year end for Aerie Pharmaceuticals?
Aerie Pharmaceuticals's fiscal year ends in December. Where is Aerie Pharmaceuticals based?
Aerie Pharmaceuticals's address is: 4301 Emperor Boulevard, Durham, NC, United States, 27703 What is Aerie Pharmaceuticals's ISIN number?
Aerie Pharmaceuticals's international securities identification number is: US00771V1089 What is Aerie Pharmaceuticals's CUSIP number?
Aerie Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00771V108
More guides on Finder
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert